Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
10.00
0.00 (0.05%)
At close: Nov 28, 2025, 1:00 PM EST
9.98
-0.01 (-0.15%)
After-hours: Nov 28, 2025, 4:48 PM EST
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $713.59 million as of November 28, 2025. Its market cap has increased by 380.55% in one year.
Market Cap
713.59M
Enterprise Value
530.97M
1-Year Change
380.55%
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $713.59M, a decrease of -8.85%. That is a compound annual growth rate of -2.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 713.59M | 360.81% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |